These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8053064)

  • 21. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection.
    Paul LC; Davidoff A; Benediktsson H; Issekutz TB
    Transplantation; 1993 May; 55(5):1196-9. PubMed ID: 8497903
    [No Abstract]   [Full Text] [Related]  

  • 23. Single-dose rituximab as induction in renal transplantation.
    van den Hoogen MW; Hilbrands LB
    Transplantation; 2010 May; 89(10):1295; author reply 1295. PubMed ID: 20555227
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of two monoclonal antibodies affecting canine transplantation reactions.
    Carreno M; Esquenazi V; Olson L; Fuller L; Alejandro R; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):612-4. PubMed ID: 2484197
    [No Abstract]   [Full Text] [Related]  

  • 25. BMA 031 effectively reverses steroid-resistant rejection in renal transplants.
    Pfeffer PF; Jakobsen A; Albrechtsen D; Sødal G; Brekke I; Bentdal O; Leivestad T; Fauchald P; Flatmark A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1099-100. PubMed ID: 1989159
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)].
    Ladefoged SD; Friedberg M; Glenthøj A
    Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080
    [No Abstract]   [Full Text] [Related]  

  • 27. Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
    Hale G; Waldmann H; Friend P; Calne R
    Transplantation; 1986 Sep; 42(3):308-11. PubMed ID: 3529531
    [No Abstract]   [Full Text] [Related]  

  • 28. Rescue therapy with interleukin-2 receptor antibody in high risk kidney transplant patients: a 3-year follow-up study.
    Carl S; Wiesel M; Daniel V; Dörsam J; Opelz G; Staehler G
    Transplant Proc; 1997; 29(1-2):320-2. PubMed ID: 9123020
    [No Abstract]   [Full Text] [Related]  

  • 29. Lymphocyte monitoring in renal transplantation.
    Burton RC
    Transplant Proc; 1984 Aug; 16(4):983-7. PubMed ID: 6380063
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
    Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
    Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation.
    Martin X; Da Silva M; Virieux SR; Hadj Aissa A; Buffet R; Tiollier J; Dubernard JM
    Transplant Proc; 2000 Mar; 32(2):481. PubMed ID: 10715487
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-CD4 therapy of acute rejection in long-term renal allograft recipients.
    Reinke P; Volk HD; Miller H; Neuhaus K; Fietze E; Herberger J; Herberger D; von Baehr R; Emmrich F
    Lancet; 1991 Sep; 338(8768):702-3. PubMed ID: 1679507
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibodies. Kidney rejection at bay.
    Wright K
    Nature; 1986 Jun 26-Jul 2; 321(6073):799. PubMed ID: 3523255
    [No Abstract]   [Full Text] [Related]  

  • 34. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.
    Kawai T; Andrews D; Colvin RB; Sachs DH; Cosimi AB
    Nat Med; 2000 Feb; 6(2):114. PubMed ID: 10655072
    [No Abstract]   [Full Text] [Related]  

  • 35. Status of monoclonals used therapeutically in transplantation.
    Kreis H; Norman D; Martin P
    Transplant Proc; 1984 Dec; 16(6):1655-7. PubMed ID: 6390880
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-LEA1 monoclonal antibody and bone marrow graft rejection in adults.
    Maraninchi D; Mawas C; Reiffers J; Gaspard MH; Laurent G; Stoppa AM; Hirn M; Delaage M
    Lancet; 1988 Sep; 2(8610):579-80. PubMed ID: 2900971
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).
    Besse T; Malaise J; Mourad M; Pirson Y; Hope J; Awwad M; White-Scharf M; Squifflet JP
    Transplant Proc; 1997 Aug; 29(5):2425-6. PubMed ID: 9270793
    [No Abstract]   [Full Text] [Related]  

  • 38. A monoclonal antibody which recognizes rabbit CD11a and which inhibits homotypic T cell aggregation.
    Blackford J; Wilkinson JM
    Biochem Soc Trans; 1993 May; 21(2):198S. PubMed ID: 8359450
    [No Abstract]   [Full Text] [Related]  

  • 39. The prophylactic use of monoclonal antibodies in renal transplantation.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):1-77. PubMed ID: 2816937
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioengineered monoclonals--easier on patients, but still hard on rejection.
    Wood RF; Pockley AG
    Transplantation; 1999 Dec; 68(11):1625-6. PubMed ID: 10609934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.